Table 4.
The pros and cons of 2D versus 3D cell culture methods
| 2D | 3D Spheroids | 3D organoids | 2D | 3D spheroids | 3D organoids | ||
|---|---|---|---|---|---|---|---|
| Easy handling/SOP | ![]() |
![]() |
![]() |
Cytoarchitecture | ![]() |
![]() |
![]() |
| Costs | ![]() |
![]() |
![]() |
High diversity of cell types | ![]() |
![]() |
![]() |
| Homogeneity | ![]() |
![]() |
![]() |
Control of environmental conditions | ![]() |
![]() |
c |
| Reproducibility | ![]() |
![]() |
![]() |
Spatial organization | ![]() |
![]() |
![]() |
| Cell–cell interactions |
a |
![]() |
![]() |
Ease of manipulation for downstream analysis | ![]() |
![]() |
![]() |
| Cell–ECM interactions | ![]() |
![]() |
![]() |
High-throughput screening | ![]() |
![]() |
d |
| Long-term culture | ![]() |
b |
![]() |
Brain Regionality | ![]() |
![]() |
![]() |
a limited to side-by-side contact; b usually to a lesser extent when compared to 3D organoids; c typically cannot have both high complexity and high variable control of environmental conditions; d less amenable due to lack of standardization
SOPs standard operating procedure, ECM extracellular matrix

















c





a









d
b


